Klasia

Business Services · United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

United States

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About Klasia

Klasia is a research and development partner specializing in innovative pharmaceuticals, focusing on establishing new distribution channels and enhancing drug planning capabilities. The company aims to ensure customer satisfaction through its competitive R&D efforts and commitment to delivering high-quality products. Klasia is dedicated to identifying and developing advanced pharmaceutical items for its clients. Their services cater to businesses seeking to innovate and improve their drug offerings.Explore more
Popular SearchesKlasia Co LtdKlasiaSIC Code 87,873NAICS Code 54,541Show more

Is Klasia your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Klasia

Compare insights from companies similar to Klasia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Klasia

<$5M
11-50
Private
-
-
N/A
$7.1M
11-50
Private
-
2001
DS
David SolomonMedical Director
<$5M
11-50
Private
-
2014
JG
Jérome GeoffroyChief Financial Officer & Strategic Board Secretary
<$5M
11-50
Private
-
-
BG
Basilio GarciaManager, Laboratory Operations & Chemist
<$5M
1-10
Private
-
2018
N/A
<$5M
11-50
Private
-
2019
<$5M
1-10
Private
-
2012
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Klasia is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Klasia is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Klasia.

Klasia Tech Stack

A closer look at the technologies used by Klasia

Top Business Services Companies

Frequently Asked Questions Regarding Klasia

What is Klasia's official website?
Klasia's official website is www.klasiapharma.com
What is Klasia's Revenue?
Klasia's revenue is <$5 Million
What is Klasia's SIC code?
Klasia's SIC: 87,873
What is Klasia's NAICS code?
Klasia's NAICS: 54,541
How many employees does Klasia have?
Klasia has 11-50 employees
What industry does Klasia belong to?
Klasia is in the industry of: Business Services, Research & Development
What is Klasia competition?
Klasia top competitors include: Carrot Capital, Orphinic Scientific, CILcare, piMedConsulting
What technology does Klasia use?
Some of the popular technologies that Klasia uses are: WordPress.org, PHP, Sectigo, The USERTRUST Network
What does Klasia do?

Klasia is a research and development partner specializing in innovative pharmaceuticals, focusing on establishing new distribution channels and enhancing drug planning capabilities. The company aims to ensure customer satisfaction through its competitive R&D efforts and commitment to delivering high-quality products. Klasia is dedicated to identify... ing and developing advanced pharmaceutical items for its clients. Their services cater to businesses seeking to innovate and improve their drug offerings.Read More

Is Klasia a public company?
Klasia is private company therefore does not currently have an official ticker symbol
See more information about Klasia

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.